ArticleClinical kidney journal2024

Tixagevimab-cilgavimab for preventing breakthrough COVID-19 in dialysis patients: a prospective study.

Sarinya Boongird et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.